Reply  by Hammer, Frank D.
sound. The patient’s aneurysm grew suddenly and rapidly to its
large size just prior to its rupture. The growth of the aneurysm
was generally paralleled by an increase in size of the patient’s liver
metastases from his pancreatic carcinoma. While it was true that
the patient was a worse candidate for surgical intervention at the
time of aneurysm rupture than at his initial surgical exploration
13 months earlier, I agree with the decision of his original sur-
geons (from another institution) to not repair his aneurysm then
since his life expectancy was so limited by his metastatic tumor.
This patient was a well-informed general and vascular surgeon
who knew the natural history of both his tumor and his aneurysm.
At all times during his course he was aware of his CT scan findings
and the enlargement of both his tumor and his aneurysm. All the
related issues were fully discussed with the patient and his family,
and it was his choice not to treat his aneurysm despite its enlarge-
ment. When the aneurysm ruptured, he was aware of the diagno-
sis and prognosis. He elected to have the aneurysm repaired at that
time. Although he survived the operation and had a feeling of
well-being for a short time, his pancreatic tumor resulted in his
demise. Having taken care of this patient during his terminal ill-
ness and having witnessed the distress of the patient and his fam-
ily, no one could be more aware than I of the importance of the
issues raised by the writers of the letter.
Frank J. Veith, MD
Division of Vascular Surgery




Regarding “Crushed stents in benign left
brachiocephalic vein stenoses”
To the Editors: 
The article by Drs Hammer, Becker, Gofette, and Mathurin1
is very important. It confirms the experience of surgeons working
with venous obstructions in the thoracic outlet who know that
stents in those positions commonly lead to complete obstruction.
The reason is twofold: (1) the previous intimal injury that those
veins have been subjected to by chronic catheters and, most
important, (2) the mechanical extrinsic compression at the tho-
racic outlet. This compression is clearly shown by the authors. In
the typical uninjured person, the vein is quite pliable, usually flat,
but changes its shape when the soft tissues relax with any type of
arm and neck motion. However, once the vein becomes rigid
with the stents, the result is predictable. The thoracic inlet is nar-
row, and the venous conduit is compressed between the aorta,
innominate arteries, subclavian arteries, and the sternum—as the
authors show in the computerized scan. Since most of these stents
are relatively long (5-8 cm or even longer), the compression
begins at the level of the first rib. For patients on dialysis who
have had fistulas in the arm and previous central dialysis catheters,
the venous return becomes critical if that vein obstructs.2,3
Therefore, my advice (like the authors’) continues to be this: if
stenosis is evident in the innominate-subclavian vein segment, the
surgeon must first decompress the channel through which this
vein runs. Doing so involves removing the first rib, the subclavius
tendon, and the anterior scalene tendon, using an anterior
approach.4 Once decompression is accomplished, then it will be
much safer to implant the stents, because there will be no struc-
tures behind to compress the venous channel that lies loosely over
the pleura. At the University of Minnesota, we have up to 13-year
follow-up data on stents placed in the innominate vein position
following surgical decompression: they have good patency. In
medical centers where this condition is treated, the subclavian
vein is most commonly the main target of stent placement.
Unfortunately, patients who have such stents placed without sur-
gical decompression of the thoracic outlet do develop obstruction
of the stented segment. This complication has been reported sev-
eral times,5,6 but these reports are apparently being ignored, so
the same mistake is being repeated.
One point the authors failed to make is that balloon angio-
plasty alone of a fibrotic or stenotic vein in the thoracic outlet
never works. The vein invariably collapses or fibroses again, so
physicians resort immediately to use of stents. This is the wrong
step, because the stent will also collapse and will invariably
obstruct the vein—as the authors have shown in the two cases
they reported here—if the thoracic outlet is not decompressed
first.5,6
I would like to emphasize, even more strongly than the
authors did, that everybody working in this area must be fully
aware that placing a stent in those veins is a no-return maneuver.
Once it is done, if the vein subsequently obstructs, the next step
is to remove the entire obstructed segment of vein and implant a
bypass graft. Since no prosthetic pliable grafts are available that
work in the venous system, we have resorted to the use of small
descending thoracic aortic homografts,7,8 which have shown
good patency after 8 years.9 However, this solution is not yet
widely available: our current use of homografts is still part of a
preliminary clinical study.
J. Ernesto Molina, MD
Cardiovascular and Thoracic Surgery
University of Minnesota Medical School
Minneapolis, Minn
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The comments of Pr. Molina are pertinent. We indeed con-
sider that stent placement in the subclavian vein or axillary vein
should be banished because of external constraints appearing dur-
ing arm and neck movements, rapidly leading to stent compres-
sion and finally stent fracture or dislocation. This has been
described in previous case reports. Therefore, as mentioned by Pr
Molina, the only viable solution in case of stent placement in this
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region is surgical decompression of the thoracic outlet before or
immediately after stent placement. One situation in which this
can be done is the Paget-Schroetter syndrome or effort throm-
bosis, after successful thrombolytic therapy.
However, I would like to underline that in our two cases
external compression of the stents occurred not in the subclavian
vein but in the innominate vein. This venous segment is intratho-
racic and usually considered to be safe for stenting. The stents
placed were short (4 cm for the Nitinol Sinus-Stent, probably ≤
4.5 cm for the Palmaz stent due to slight over dilatation) and
located beyond the subclavian-jugular confluence. We therefore
believe that in this situation surgical decompression of the tho-
racic outlet would have been ineffective. The mechanism of exter-
nal compression in this region is different from a subclavian
compression, and does not result from arm movements or
impingement between the first rib and clavicle, but from com-
pression between the manubrium and aortic arch. The phlebo-
graphic studies from Tanaka et al,1 performed during respiratory
movements, support this hypothesis.
I agree with Pr. Molina that stent placement is a “no-return
maneuver.” Surgery of the left brachiocephalic vein is very aggres-
sive and technically challenging (midsternal incision), usually
requiring a bypass from the left internal jugular vein to the right
atrial appendage. In addition, results are jeopardized by graft
stenosis or thrombosis. We would therefore suggest, as we did in
our conclusion, to consider conservative treatment first (with AV
fistula closure), since congestive symptoms will usually resolve
progressively with the development of collateral veins.
Frank D. Hammer, MD
Department of Radiology and Medical Imaging
University Hospital St Luc
Brussels, Belgium
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Regarding “Dacron carotid patch infection: a report
of eight cases”
To the Editors:
I read with interest the recent article by Dr Rizzo and col-
leagues (J Vasc Surg 2000;32:602-6) on management of Dacron
carotid patch infections. Three patients presented late (236, 750,
1060 days after endarterectomy), while five patients presented more
acutely (mean, 28.6 days; range, 13-43). The late infections were all
managed with patch excision and interposition vein grafts, while the
early infections were treated with replacement of the Dacron patch
with a vein patch. These procedures were clearly difficult, even in
the hands of the experienced surgeons at the Cleveland Clinic1;
there was a 25% (2/8) incidence of cranial nerve injury and 12.5%
(1/8) risk of myocardial infarction and stroke. In light of this sub-
stantial morbidity, are there other treatment options?
In those patients presenting late (> 6 months), some with
pseudoaneurysms, no other treatment strategy seems reasonable.
However, in patients presenting more acutely after endarterec-
tomy, operative drainage of the infection with preservation of the
Dacron patch may be an option. In a personal series of 201 con-
secutive carotid endarterectomies (CEAs) performed between
August 1996 and August 2000, 80% (161) were closed with a
Dacron patch, 0.5% (1) closed with a vein patch, 14.9% (30)
closed primarily, and 4.5% (9) underwent internal carotid artery
(ICA) shortening with use of redundant ICA as an autogenous
patch. In this series, two patients closed with a Dacron patch
(1.2% [2/161]) and presented with early infection, similar to the
1.8% reported by Rizzo et al. No late infections have occurred.
Patient 1: A 69-year-old male without diabetes mellitus under-
went CEA with Dacron closure October 1996. The operation
was fairly difficult, with plaque extending well past the
hypoglossal nerve, requiring division of the occipital artery and
posterior digastric muscle in order to obtain distal control. He
presented 12 days later with local neck erythema, tenderness,
and swelling. A duplex ultrasound revealed no pseudoaneurysm
or residual stenosis. He was taken to the operating room with
plans to replace the Dacron patch with saphenous vein. Gross
purulence was found deep to the platysma. Cultures grew alpha-
hemolytic streptococcus. The distal ICA dissection was very
treacherous because of severe inflammation and the previous
high exposure; adequate distal exposure could not be safely
obtained. Thus, after copious irrigation, the sternocleidomastoid
muscle was tacked over the patch, and the platysma, subcuta-
neous tissues, and skin were left open. This wound healed
within 1 month, and at 46 months of follow-up, he has had no
evidence of further infection.
Patient 2: A 52-year-old female with diabetes mellitus under-
went CEA with Dacron patch closure September 1999 and pre-
sented 17 days later with neck swelling, tenderness, and
erythema. Duplex ultrasound revealed no pseudoaneurysm. At
surgery, gross purulence deep to the platysma was confirmed.
Cultures grew alpha-hemolytic streptococcus. After thorough
irrigation, the sternocleidomastoid was tacked over the
endarterectomy site with the remainder of the incision left open.
With routine wound care, complete healing was observed in 2
weeks. At 11 months’ follow-up, the patient shows no evidence
of recurrent infection.
Both of these patients presented early with infection from a
pan-sensitive skin fluora. Successful preservation of the Dacron
patch was obtained with aggressive drainage and irrigation,
sternocleidomastoid myoplasty, and routine wound care to the
opened incision. No cranial nerve injuries, strokes, or other mor-
bidity occurred.
Removal of all foreign material from an infected wound is sur-
gical dogma; many would consider it heresy not to do so in a con-
taminated vascular wound. However, selective nonexcisional
treatment of infected wounds containing vascular prosthetic
patches has been successful in other vascular beds,2 including the
carotid position.3 The fairly indolent nature of the alpha strep
encountered in these two patients may also have contributed to a
successful outcome. While no firm treatment recommendations
can be espoused on the basis of a few patients, it seems reasonable
to suggest that simple drainage should not be applied to carotid
patch infections presenting late; one patient in the series from
Rizzo et al had this performed at an outside facility and then pre-
sented with patch disruption and hemorrhage. However, in
patients presenting early after CEA (< 4-6 weeks) who do not have
a pseudoaneurysm, aggressive surgical drainage, myoplasty, and
wound care have been successful anecdotally. Importantly, the sig-
nificant morbidity associated with early reoperative carotid surgery
in an infected field, as documented by Rizzo et al, is avoided.
The reporting of these two cases should suggest neither
unbridled enthusiasm for nor confidence in the therapy employed.
Treatment decisions must be individualized. Unfortunately, there
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